UroGen Pharma Ltd.
URGN
$18.44
-$0.35-1.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.18% | -19.06% | -19.88% | -17.24% | -5.16% |
| Total Receivables | 67.90% | 0.27% | 0.06% | -3.27% | -10.96% |
| Inventory | 97.39% | 17.02% | -6.09% | -17.74% | 21.50% |
| Prepaid Expenses | 21.04% | 0.56% | -7.15% | 46.78% | -37.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.22% | 24.49% | 0.56% | 0.00% | 0.28% |
| Total Current Assets | 10.37% | -14.39% | -17.00% | -14.11% | -6.43% |
|
|
|||||
| Total Current Assets | 10.37% | -14.39% | -17.00% | -14.11% | -6.43% |
| Net Property, Plant & Equipment | -0.99% | 47.20% | 15.97% | 41.99% | 128.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.04% | 609.20% | 78.79% | -28.50% | 40.37% |
| Total Assets | 8.33% | -11.34% | -15.71% | -13.33% | -5.38% |
|
|
|||||
| Total Accounts Payable | 18.08% | -24.22% | -6.89% | 33.26% | 96.74% |
| Total Accrued Expenses | 7.73% | -7.01% | 27.82% | -16.06% | 16.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.52% | 2.58% | 9.48% | -7.58% | 85.45% |
| Total Finance Division Other Current Liabilities | 1.81% | -0.68% | 2.88% | -48.63% | 97.60% |
| Total Other Current Liabilities | 1.81% | -0.68% | 2.88% | -48.63% | 97.60% |
| Total Current Liabilities | 9.88% | -11.16% | 13.21% | -8.59% | 40.14% |
|
|
|||||
| Total Current Liabilities | 9.88% | -11.16% | 13.21% | -8.59% | 40.14% |
| Long-Term Debt | 0.08% | -0.32% | 0.33% | 0.31% | 0.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.91% | 82.86% | 20.13% | 71.87% | 679.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.02% | 0.96% | 1.18% | 1.56% | 2.84% |
| Total Liabilities | 1.82% | -0.54% | 2.73% | -0.15% | 6.54% |
|
|
|||||
| Common Stock & APIC | 4.44% | 1.40% | 0.38% | 0.78% | 0.42% |
| Retained Earnings | -2.82% | -3.71% | -5.87% | -5.44% | -4.88% |
| Treasury Stock & Other | -17.39% | 283.33% | -57.14% | -75.00% | -76.27% |
| Total Common Equity | 8.61% | -23.59% | -100.99% | -427.75% | -134.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.61% | -23.59% | -100.99% | -427.75% | -134.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.61% | -23.59% | -100.99% | -427.75% | -134.50% |
|
|
|||||